LakeShore Biopharma Co., Ltd: eps_basic
| Value | {"per": "shares", "amount": -4.05, "concept": "us-gaap:EarningsPerShareBasic", "currency": "CNY"} |
|---|---|
| Period | 2023-04-01 – 2024-03-31 |
| Status | superseded |
| Entity | LakeShore Biopharma Co., Ltd |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T18:58:48.545571+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/10460c67-4c2d-4c7a-bfa9-b7a0a0ecedac
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001213900-24-069344Retrieved: 2026-08-19T18:58:48.545571+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001946399/eps-basic/2024-03-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/10460c67-4c2d-4c7a-bfa9-b7a0a0ecedac
History
- no predecessors — first report